Vanda Pharmaceuticals(VNDA) Stock Price Today

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

Insider Purchase: President and CEO of $VNDA Buys 10,000 Shares
Quiver QuantitativeFeb 25 19:45 ET
Express News | Vanda Pharmaceuticals Announces the Publication of an Article Titled "Potential Aso-Based Personalized Treatment for Charcot-Marie-Tooth Disease Type 2S"
ReutersFeb 24 07:00 ET
Vanda Pharmaceuticals Announces the Publication of an Article Titled "Potential ASO-based Personalized Treatment for Charcot-Marie-Tooth Disease Type 2S"
Yahoo FinanceFeb 24 07:00 ET
The Analyst Verdict: Vanda Pharma In The Eyes Of 5 Experts
BenzingaFeb 18 07:00 ET
Vanda Pharma Analyst Ratings
BenzingaFeb 18 06:48 ET · Ratings
H.C. Wainwright Maintains Vanda Pharmaceuticals(VNDA.US) With Buy Rating, Raises Target Price to $20
Moomoo NewsFeb 18 06:31 ET · Ratings

Comments

Jaguar8

Mar 2 18:34

🟠Watchlist, MARCH 3,2025, Monday. NFA - DrJag8. (Comments are off since I will be off for PM and RTH tomorrow)

NOTE!
1. NFA (Not Financial Advice!) This is NOT a BUY or SELL advice.
2. Do NOT open position WITHOUT chart confirmation, indicators, momentum.
3. Scale out and secure profits.
4. Most importantly, DON’T BLAME ME for your losses. Your trade, your accountability.
5. I DO NOT give buy or sell advice
6 COH (cash on hand); AH (after hours): RTH (regular trading hours); PR (press release; F...

79

6

Teddy123

Feb 24 06:07

Vanda Pharmaceuticals announces the publication of an article titled "Potential ASO-based personalized treatment for Charcot-Marie-Tooth disease type 2S"

$Vanda Pharmaceuticals (VNDA.US)$
Can This Personalized Gene Therapy Revolutionize Rare Disease Treatment? Vanda's Latest Breakthrough

Teddy123

Feb 13 18:22

Vanda Pharmaceuticals Reports Fourth Quarter and Full Year 2024 Financial Results

$Vanda Pharmaceuticals (VNDA.US)$
Vanda's Earnings Show 17% Growth Despite Losses: Major Pipeline Expansion Could Triple Revenue

Jaguar8

Feb 13 15:01

NEWS ER

$Vanda Pharmaceuticals (VNDA.US)$
Vanda Pharmaceuticals Reports Fourth Quarter and Full Year 2024 Financial Results
Thursday, 13th February at 4:01 pm
Q4 2024 total revenues of $53.2 million, +17% compared to Q4 2023
Q4 2024 Fanapt® net product sales of $26.6 million, +18% compared to Q4 2023
Full year 2024 total revenues of $198.8 million, +3% compared to full year 2023
Full year 2025 revenue expected to grow to $210 to $250 million
Psychiatry portfolio revenue expected to grow to greate...

1

Jaguar8

Feb 6 20:51

🟠Watchlist, FEBRUARY 7,2025, Friday. NFA- DrJag8 (I am not sure if I’ll be trading tomorrow)

NOTE!
1. NFA (Not Financial Advice!) This is NOT a BUY or SELL advice.
2. Do NOT open position WITHOUT chart confirmation, indicators, momentum.
3. Scale out and secure profits.
4. Most importantly, DON’T BLAME ME for your losses. Your trade, your accountability.
5. I DO NOT give buy or sell advice
6 COH (cash on hand); AH (after hours): RTH (regular trading hours); PR (press release; FCF (free cash flow...

59

8

4

VNDA Vanda Pharmaceuticals

Trade Overview

Capital Trend

News

Comments

Trending Stocks